Clinical significance of neoadjuvant chemotherapy for locally advanced colorectal cancer patients with deficient mismatch repair: possibly residual value in the era of immunotherapy.
Mian ChenJunguo ChenJun HuangHuashan LiuWuteng CaoShuangling LuoZhanzhen LiuHuanxin HuSicong LaiYujie HouLiang KangLiang HuangPublished in: Therapeutic advances in gastroenterology (2023)
In this study, NAC was associated with better tumor downstaging and longer 5-year DFS in LACC patients with dMMR. Consequently, NAC might be an additional treatment choice when it comes to such patients in the future.